Hypertrophic Cardiomyopathy in Cats: The Silent Heart Condition

Hypertrophic cardiomyopathy, or HCM, is the most common heart disease in cats worldwide. It affects an estimated 10–15% of all domestic cats, making it one of the most prevalent cardiac conditions in veterinary medicine. In HCM, the muscular walls of the heart — particularly the left ventricle — become abnormally thickened. This thickening reduces the volume of the heart chamber, impairing the heart's ability to fill with blood properly during relaxation. Over time, the stiffened heart muscle creates back-pressure that can lead to fluid accumulation in and around the lungs, dangerous blood clot formation, and ultimately heart failure.

"HCM is the condition that keeps me most vigilant as a feline cardiologist. A cat can have severely thickened heart walls and appear perfectly healthy for years — eating, playing, purring — and then present in a life-threatening crisis seemingly overnight. This is why I strongly advocate for cardiac screening in all breeds with known predisposition and why I always listen carefully during routine examinations for any subtle heart murmur or gallop sound." — Dr. Sarah Chen, DVM

What makes HCM particularly challenging is its silent nature. Unlike many diseases that produce gradual, visible symptoms, HCM frequently develops without any outward signs. Cats are masters at concealing illness, and the heart's ability to compensate for thickened walls means that many cats live with significant cardiac disease for years before a crisis occurs. In some tragic cases, the first indication of HCM is sudden death or an acute thromboembolism — a blood clot that blocks blood flow to the hind legs.

Despite its serious nature, HCM is manageable in many cases. Early detection through regular veterinary examinations and appropriate screening gives cats the best possible chance at a long, comfortable life. This guide explains what every cat owner should know about this silent but significant heart condition.

HCM in cats has both genetic and acquired causes, though the genetic (primary or idiopathic) form is by far the most common. Understanding the underlying causes helps identify cats that need proactive cardiac monitoring.

Genetic HCM

The majority of HCM cases are inherited. In Maine Coons and Ragdolls, specific genetic mutations have been identified in the MYBPC3 gene (myosin-binding protein C), which is involved in the structural integrity of heart muscle cells. Genetic testing is available for these breeds, though it is important to understand that a negative genetic test does not guarantee freedom from HCM — other unidentified mutations may also cause the disease. Maine Coons carry one of the highest breed risks, with studies estimating HCM prevalence of 26–33% in the breed. Ragdolls have a distinct MYBPC3 mutation with similar implications.

Other breeds with recognised predisposition include British Shorthairs, Persians, Sphynx cats, Bengal cats, Norwegian Forest Cats, and Scottish Folds. However, HCM is not limited to pedigree cats — domestic shorthairs and longhairs are commonly affected, and in fact represent the majority of HCM cases seen in veterinary practice simply because they are the most numerous cat population.

Secondary Causes

In some cases, the heart thickening associated with HCM is secondary to another condition rather than a primary cardiac disease. The most important secondary cause is hyperthyroidism — an overactive thyroid gland that is extremely common in older cats. Elevated thyroid hormones increase heart rate and cardiac workload, leading to compensatory hypertrophy of the heart muscle. Systemic hypertension (high blood pressure), often secondary to chronic kidney disease, can produce similar cardiac changes. Acromegaly (excess growth hormone) and subaortic stenosis are rarer causes. Identifying and treating these secondary causes may partially or completely reverse the cardiac changes.

Age and Sex

HCM can develop at any age, from kittens under one year to elderly cats over fifteen. However, diagnosis is most common in middle-aged cats between five and seven years old. Male cats are more commonly affected than females in most studies, and tend to develop more severe disease. The wide age range underscores the importance of cardiac auscultation at every veterinary visit throughout a cat's life.

The clinical presentation of HCM ranges from no symptoms at all to sudden life-threatening emergencies. Understanding the full spectrum helps owners recognise when something may be wrong.

The Silent Phase

Many cats with HCM — potentially the majority — never show symptoms during their lifetime. These cats may carry the disease for years and die of other causes. A heart murmur detected during a routine examination may be the only clue to underlying HCM. Not all murmurs indicate HCM (innocent or functional murmurs are common in cats), but any new murmur warrants investigation with echocardiography.

Subtle Early Signs

When symptoms do develop, they are often subtle and easily overlooked:

• Reduced activity and increased sleeping — often dismissed as normal feline behaviour or attributed to ageing
• Mild, intermittent open-mouth breathing after exertion — cats should never pant like dogs; any open-mouth breathing is abnormal
• Decreased appetite or subtle weight changes
• Hiding more than usual — cats instinctively seek isolation when they feel unwell. If you notice behavioural changes suggesting discomfort, consult your veterinarian

Congestive Heart Failure

When the thickened heart can no longer compensate, fluid accumulates in or around the lungs (pulmonary oedema or pleural effusion). Symptoms of congestive heart failure include:

• Rapid or laboured breathing — a resting respiratory rate consistently above 30 breaths per minute is concerning
• Open-mouth breathing at rest — this is always a veterinary emergency in cats
• Lethargy and weakness — a cat that is normally active becoming profoundly quiet and withdrawn
• Loss of appetite — complete food refusal often accompanies severe heart failure

Arterial Thromboembolism (ATE) — The Most Feared Complication

Arterial thromboembolism, commonly known as a saddle thrombus, is one of the most devastating complications of HCM. Blood clots form in the enlarged left atrium and are ejected into the bloodstream, most commonly lodging at the aortic trifurcation — the point where the aorta splits to supply the hind legs. The result is sudden, severe pain and paralysis of one or both hind legs. Affected cats cry out in distress, drag their hind legs, and the affected limbs feel cold with pale or blue-tinged nail beds. ATE is a medical emergency requiring immediate veterinary care. Approximately 40–50% of cats experiencing ATE for the first time may be euthanised due to the severity of the episode or the poor prognosis for recurrence.

Early diagnosis of HCM provides the best opportunity for intervention before complications develop. Several diagnostic tools are available, each providing different but complementary information.

Echocardiography — The Gold Standard

An echocardiogram performed by a veterinary cardiologist or experienced ultrasonographer is the definitive test for HCM. It directly measures the thickness of the heart walls — a left ventricular free wall or interventricular septum thickness greater than 6 millimetres in diastole (when the heart is relaxed) is diagnostic for hypertrophy. The echocardiogram also evaluates left atrial size (enlargement increases thromboembolism risk), the presence of spontaneous echo contrast (swirling blood in the atrium — a precursor to clot formation), and overall heart function. Doppler assessment detects abnormal blood flow patterns, including dynamic left ventricular outflow tract obstruction (LVOTO), which occurs in a subset of HCM cats.

Physical Examination

Careful auscultation (listening with a stethoscope) during routine examinations can detect heart murmurs, gallop rhythms (an additional heart sound indicating cardiac dysfunction), and arrhythmias. However, up to 50% of cats with HCM may not have an audible murmur, which is why auscultation alone cannot reliably rule out the disease. Conversely, many cats with murmurs do not have HCM — innocent flow murmurs are common, particularly in stressed or anaemic cats.

Cardiac Biomarkers

Blood tests for cardiac biomarkers offer a practical screening tool. Cardiac troponin I (cTnI) is released when heart muscle cells are damaged and is often elevated in cats with HCM. NT-proBNP is elevated when the heart is stretched or under increased wall stress. These tests are not diagnostic on their own but serve as effective screening tools — an elevated biomarker in an apparently healthy cat provides strong justification for echocardiographic evaluation. They are particularly useful for cats about to undergo anaesthesia, where undiagnosed heart disease carries additional risk.

Genetic Testing

DNA tests are available for the MYBPC3 mutations identified in Maine Coons and Ragdolls. A positive result confirms that the cat carries the mutation and is at increased risk of developing HCM, warranting regular echocardiographic screening. However, a negative result does not exclude HCM, as other undiscovered mutations may be responsible. Genetic testing is most valuable as a breeding tool — removing carriers from breeding programmes reduces disease prevalence in future generations.

Ruling Out Secondary Causes

Blood work should always include thyroid hormone levels (T4) in cats over six years old, as hyperthyroidism is a treatable cause of cardiac hypertrophy. Blood pressure measurement is also essential, as systemic hypertension secondary to chronic kidney disease or other conditions can mimic primary HCM. Successfully treating these underlying conditions may improve or resolve the cardiac changes.

Treatment of HCM is tailored to the individual cat's disease stage and symptoms. There is currently no treatment that reverses the heart muscle thickening, but medications can manage symptoms, reduce the risk of complications, and improve quality of life.

Asymptomatic Cats with Mild HCM

For cats with mild hypertrophy (wall thickness 6–7 mm), a normal-sized left atrium, and no symptoms, the approach is often monitoring without medication. Regular echocardiographic rechecks — typically every six to twelve months — track disease progression. Some cardiologists prescribe a beta-blocker (atenolol) in cats with significant LVOTO or very rapid heart rates, though the evidence for treating asymptomatic cats without obstruction remains debated.

Moderate to Severe HCM Without Heart Failure

Cats with more significant hypertrophy, left atrial enlargement, or evidence of diastolic dysfunction may benefit from:

• Beta-blockers (atenolol) — slow the heart rate, allowing more time for the ventricle to fill with blood and reducing myocardial oxygen demand
• Calcium channel blockers (diltiazem) — an alternative to beta-blockers that may improve ventricular relaxation
• Clopidogrel (Plavix) — an antiplatelet medication strongly recommended for cats with a moderately to severely enlarged left atrium to reduce thromboembolism risk. The FAT CAT study demonstrated that clopidogrel significantly reduces recurrent ATE compared to aspirin

Heart Failure Management

When congestive heart failure develops, treatment focuses on removing accumulated fluid and maintaining cardiac output:

• Furosemide — essential for clearing pulmonary oedema and pleural effusion; dose is carefully titrated to balance fluid removal against kidney function
• Thoracocentesis — if pleural effusion is causing severe breathing difficulty, needle drainage of fluid from the chest cavity provides immediate relief
• ACE inhibitors (benazepril) — may provide neurohormonal benefits in heart failure management, though evidence in cats is limited
• Clopidogrel — essential in heart failure patients due to the very high risk of ATE

ATE Treatment

Cats presenting with acute thromboembolism require emergency care including aggressive pain management (ATE is extremely painful), supportive care, and anticoagulation therapy. If the cat survives the initial crisis and regains hind limb function — which occurs in approximately 40–50% of cases — long-term clopidogrel and careful cardiac management are essential to reduce recurrence risk. The decision to treat or euthanise during an acute ATE episode is deeply personal and should be made in partnership with your veterinarian based on the severity of the episode and your cat's overall cardiac status.

The prognosis for cats with HCM varies enormously depending on disease severity and the presence of complications. Understanding the range of outcomes helps owners plan and cope with the diagnosis.

Prognosis by Disease Stage

Cats with mild, stable HCM and a normal left atrial size may live a normal lifespan — many are diagnosed incidentally and never develop clinical signs. These cats may simply require monitoring without treatment for years. Cats with moderate disease and left atrial enlargement have a more guarded prognosis, with increased risk of heart failure and thromboembolism. Median survival after congestive heart failure onset in cats with HCM is approximately twelve to eighteen months with treatment, though individual outcomes vary widely — some cats survive only weeks while others live three or more years with careful management.

The single worst prognostic indicator is arterial thromboembolism. Cats that survive an initial ATE episode have a median survival of approximately two to six months, with a high risk of recurrence despite clopidogrel therapy. However, some cats defy these statistics and live over a year after an ATE event.

Home Monitoring Essentials

Owners of cats with HCM can dramatically improve outcomes through diligent home monitoring:

• Sleeping respiratory rate (SRR) — count breaths while your cat sleeps peacefully. A normal SRR is typically under 30 breaths per minute. An upward trend from your cat's baseline — even if still below 30 — warrants a call to your vet. Many cardiologists consider the SRR the most sensitive home monitoring tool available
• Activity and appetite tracking — keeping a simple daily log of how much your cat eats, plays, and interacts helps detect subtle changes before they become crises
• Medication compliance — giving medications consistently at the same times each day optimises their effectiveness. Many cats tolerate tablets wrapped in pill pockets or mixed with a small amount of food

Lifestyle Considerations

Cats with HCM do not generally require activity restriction unless they are in heart failure. Most cats self-regulate their activity levels naturally. Stress reduction is beneficial — minimise major environmental changes, provide quiet retreat spaces, and consider pheromone diffusers if your cat is anxious. A good quality, balanced diet supports overall health; sodium restriction may be recommended for cats in heart failure but is typically unnecessary for stable cats. Work closely with your veterinary team to establish a monitoring and recheck schedule tailored to your cat's disease stage.

A diagnosis of HCM, while serious, does not mean your cat cannot enjoy many more happy years. With vigilant monitoring, dedicated care, and a strong partnership with your vet, many HCM cats continue to live fulfilling lives.